Lundbeck replaces retiring CEO Deborah Dunsire with UCB exec after breaking sales record

Lundbeck CEO Deborah Dunsire is stepping down on a high note in the neuroscience company’s history. Dunsire has decided to retire from Lundbeck, the Danish company said Monday. Charl van Zyl, head of neurology solutions at UCB, has been hired to succeed Dunsire no later than Oct. 1.